First Training on the Treatment of the Harms Produced by Novel Psychoactive Substances and Club Drugs

 

On the 7th of October 2020 the first of a series of five training sessions on the treatment of the harms produced by novel psychoactive substances and club drugs is being delivered online to specialists from 5 countries.

The activity is being delivered by EU-ACT Project, in conjunction with the EU4MD, European Union 4 Monitoring Drugs, a Project of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); and the Novel Psychoactive Treatment United Kingdom Network (NEPTUNE) of the United Kingdom National Health Service (NHS).

Due to the current pandemic situation, the training sessions will be delivered entirely in an on-line format, with between 3 to 5 clinicians and psychiatrists from Belarus, Georgia, Moldova, Pakistan and Ukraine in attendance.

The training is to be delivered by Dr Dima Abdulrahim and Dr Owen Bowden-Jones, the experts from the Novel Psychoactive Treatment UK Network (NEPTUNE), who developed the 'Guidance on the Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances'. 

For these time-limited sessions, the NEPTUNE Club Drugs and NPS guidance has been adapted and simplified. It is divided into four titles: a general executive summary; hallucinogens and Synthetic Cannabinoid Receptor Agonists (SCRAs); stimulants; and depressants; and it has been translated into Russian, Ukrainian, Georgian, and Romanian (Moldova) languages. 

These sessions aim at increasing awareness of the latest trends in treating the effects on the persons of the new psychoactive substances, and club drugs such as ecstasy and ketamine. It is intended as a train of trainers' activity, to improve the knowledge on this subject within a limited number of key specialists per country, so that these key specialists could adapt and introduce this expertise at the relevant educational level into their respective countries.